Fundraising Fox

Amlogenyx

Novato, US · Founded 2023 · Delaware corporation

Biotech

Founders & leadership

TH
TED HUIZENGAExecutive
TK
TOM KASSBERGExecutive
JP
JOHN PINIONExecutive
KP
Karah ParschauerExecutive
EK
EMIL KAKKISNamed on SEC filing

Board

CG
CRAIG GORDONBoard director
SN
SUKUMAR NAGENDRANBoard director

Reported raises · per SEC filings

Form D private placements

$24M disclosed across 2 rounds · 2024–2026

▶$10MraisedJul 2026 · 2 investors · Biotechnology
Rule 506(b)
Amlogenyx Presents Preclinical Data on AM805, a Potentially Transformative Investigational Gene Therapy for Alzheimer’s Diseaseglobenewswire.com · May 2026 · press release
Officers, directors & promoters on the filing
  • TED HUIZENGAExecutive Officer
  • JOHN PINIONExecutive Officer
  • CRAIG GORDONDirector
  • EMIL KAKKISExecutive Officer, Director
  • SUKUMAR NAGENDRANDirector
  • Karah ParschauerExecutive Officer
Offering amount
$20M
Amount sold
$10M
First sale
Jul 2026
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14MraisedAug 2024 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • EMIL KAKKISExecutive Officer, Director
  • CRAIG GORDONDirector
  • TED HUIZENGAExecutive Officer
  • TOM KASSBERGExecutive Officer
  • JOHN PINIONExecutive Officer
Offering amount
$14M
Amount sold
$14M
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Amlogenyx Presents Preclinical Data on AM805, a Potentially Transformative Investigational Gene Therapy for Alzheimer’s Diseaseglobenewswire.com · May 2026 · press releaseFollow the Money: AI-Powered Cell Therapies, Cancer Risk Assessment, Morebio-itworld.com · Aug 2024Follow the Money: Oncology, Autoimmunity, Breast, Prostate Clinical Trials, T Cell Products, Moreclinicalresearchnewsonline.com · Aug 2024Amlogenyx Closes USD14M Seed Fundingfinsmes.com · Aug 2024Amlogenyx Inc. Closes Successful Seed Funding Led by GordonMD® Global Investments LPbusinesswire.com · Aug 2024Amlogenyx Inc. announced that it has received $13.99999 million in funding from GordonMD Global Investments LP, Ultragenyx Pharmaceutical Inc. and other investors | MarketScreenermarketscreener.com · Aug 2024

Frequently asked questions

How much funding has Amlogenyx raised?
Amlogenyx has disclosed $24M raised across 2 rounds.
Where is Amlogenyx headquartered?
Amlogenyx is headquartered in Novato, US.